Reboxetinemesylate
CAS : 71620-89-8
Ref. 3D-FR148959
1g | 865,00 € | ||
50mg | 194,00 € | ||
100mg | 309,00 € | ||
250mg | 473,00 € | ||
500mg | 645,00 € |
Informations sur le produit
- (2R)-2-[(R)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine
- (2R)-2-[(R)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine methanesulfonate (1:1)
- (2S)-2-[(S)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine
- (S,S)-2-[(2-ethoxyphenoxy)-phenylmethyl] morpholine
- 2-[(2-Ethoxyphenoxy)(Phenyl)Methyl]Morpholine
- Axs 12
- Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-
- Norebox
- Prolift
- Reboxitine
- Voir d'autres synonymes
- Vestra
- rel-(2R)-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine
- Reboxetine
Reboxetinemesylate is a prodrug that is converted to reboxetine, the active form of the drug. It has been shown to be effective in the treatment of symptoms related to depression and Parkinson's disease. Reboxetinemesylate has a long-term efficacy due to its long half-life and slow release from plasma proteins. This drug may have drug interactions with other medications, such as hepatic impairment or drugs that are metabolized by CYP450 enzymes. Reboxetinemesylate also has locomotor activity effects on rats, which may be due to dopamine receptor agonist properties. Reboxetinemesylate is not active against bacterial infections, but is used for the treatment of Parkinson's disease and depression.
Propriétés chimiques
Question d’ordre technique sur : 3D-FR148959 Reboxetinemesylate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages